These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14585258)

  • 1. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer.
    Maduro JH; Pras E; Willemse PH; de Vries EG
    Cancer Treat Rev; 2003 Dec; 29(6):471-88. PubMed ID: 14585258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of concurrent radiotherapy and chemotherapy for locally advanced cervical cancer: 12-Year survival after radiochemotherapy.
    Berclaz G; Gerber E; Beer K; Aebi S; Greiner R; Dreher E; Buser K
    Int J Oncol; 2002 Jun; 20(6):1313-8. PubMed ID: 12012015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysis.
    Gondi V; Bentzen SM; Sklenar KL; Dunn EF; Petereit DG; Tannehill SP; Straub M; Bradley KA
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):973-82. PubMed ID: 22898381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
    Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
    [No Abstract]   [Full Text] [Related]  

  • 7. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer.
    Kirwan JM; Symonds P; Green JA; Tierney J; Collingwood M; Williams CJ
    Radiother Oncol; 2003 Sep; 68(3):217-26. PubMed ID: 13129628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute toxicity of chemo-radiotherapy for cervical cancer: the Addenbrooke's experience.
    Tan LT; Russell S; Burgess L
    Clin Oncol (R Coll Radiol); 2004 Jun; 16(4):255-60. PubMed ID: 15214649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K; Jassem J
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects.
    King M; McConkey C; Latief TN; Hartley A; Fernando I
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):38-45. PubMed ID: 16477918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Referee: hyperthermia alone or combined with cisplatin in addition to radiotherapy for advanced uterine cervical cancer.
    Dahl O; Mella O
    Int J Hyperthermia; 2002; 18(1):25-30. PubMed ID: 11820464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current methods of chemoradiotherapy for locally advanced cervical cancer. Options for reduction of side-effects].
    Póti Z; Mayer A
    Orv Hetil; 2013 May; 154(21):803-9. PubMed ID: 23692874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes and toxicity of postoperative intensity-modulated versus three-dimensional conformal radiation therapy in patients with cervical cancer.
    Lan ML; Yu X; Xiao H; Zhou P; Hu N; Li J; Wang G
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):430-436. PubMed ID: 26923341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative intensity-modulated arc therapy for cervical and endometrial cancer: a prospective report on toxicity.
    Vandecasteele K; Tummers P; Makar A; van Eijkeren M; Delrue L; Denys H; Lambert B; Beerens AS; Van den Broecke R; Lambein K; Fonteyne V; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):408-14. PubMed ID: 22377596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of Cancer.
    Uitterhoeve AL; Belderbos JS; Koolen MG; van der Vaart PJ; Rodrigus PT; Benraadt J; Koning CC; González González D; Bartelink H
    Eur J Cancer; 2000 Mar; 36(5):592-600. PubMed ID: 10738123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insufficiency fractures in patients treated with pelvic radiotherapy and chemotherapy for uterine and cervical cancer.
    Mehmood Q; Beardwood M; Swindell R; Greenhalgh S; Wareham T; Barraclough L; Livsey J; Davidson SE
    Eur J Cancer Care (Engl); 2014 Jan; 23(1):43-50. PubMed ID: 23889218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
    Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M
    Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
    Lorvidhaya V; Chitapanarux I; Sangruchi S; Lertsanguansinchai P; Kongthanarat Y; Tangkaratt S; Visetsiri E
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1226-32. PubMed ID: 12654431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.
    Lee AW; Tung SY; Chua DT; Ngan RK; Chappell R; Tung R; Siu L; Ng WT; Sze WK; Au GK; Law SC; O'Sullivan B; Yau TK; Leung TW; Au JS; Sze WM; Choi CW; Fung KK; Lau JT; Lau WH
    J Natl Cancer Inst; 2010 Aug; 102(15):1188-98. PubMed ID: 20634482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.